COL4A5 and Alport syndrome: To determine the molecular effect of metformin and losartan on glomeruli in Col4a5 G5X Alport syndrome mice, we assessed the global mRNA expression profile in glomeruli of WT and Alport syndrome mice treated with vehicle, metformin, or losartan for 6 weeks.